Klotho Neurosciences, Inc. Common Stock (KLTO) is a publicly traded Healthcare sector company. As of May 21, 2026, KLTO trades at $0.52 with a market cap of $56.66M and a P/E ratio of -2.36. KLTO moved -0.20% today. Year to date, KLTO is -2.66%; over the trailing twelve months it is +85.36%. Its 52-week range spans $0.11 to $3.91. Rallies surfaces KLTO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own KLTO include Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Klotho Neurosciences, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $0.52 |
| Market Cap | $56.66M |
| P/E Ratio | -2.36 |
| EPS | $-0.22 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.91 |
| 52-Week Low | $0.11 |
| Volume | 2.35M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-10.55M |
| Gross Margin | 0.00% |
KLTO analyst coverage data. Average price target: $0.00.